MiNK Therapeutics
INKT
INKT
17 hedge funds and large institutions have $544K invested in MiNK Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.78K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.82K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$914 |
| 5 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$121 |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$70.9K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$35.3K |
| 3 |
State Street
Boston,
Massachusetts
|
-$17.8K |
| 4 |
GWM
Greenwich Wealth Management
Greenwich,
Connecticut
|
-$8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$7.97K |
